Management of Massive Upper Gastrointestinal Bleeding
In a patient with massive upper gastrointestinal bleeding, immediately prioritize aggressive volume resuscitation and hemodynamic stabilization before attempting source identification, with the most common nonvariceal sources being peptic ulcers (duodenal and gastric), gastric erosions, Mallory-Weiss tears, and Dieulafoy lesions, followed by urgent upper endoscopy within 24 hours (or emergently if hemodynamically unstable despite resuscitation) for both diagnosis and therapeutic intervention. 1, 2
Most Likely Sources
The etiology varies by whether bleeding is variceal or nonvariceal:
Nonvariceal Sources (Most Common Overall)
- Peptic ulcer disease (duodenal ulcer, gastric ulcer) - most frequent cause 1, 2
- Gastric erosions 1
- Mallory-Weiss tears 1
- Dieulafoy lesion - accounts for 1-2% but often severe; tortuous submucosal artery penetrating mucosa, typically at posterior gastric wall 1
- Esophagitis and duodenitis 1
- Malignant tumors 1
- Angiodysplasia and vascular malformations 1
Variceal Sources
Rare but Catastrophic Sources
- Aortoenteric fistula - potentially catastrophic 1
- Hemobilia and hemosuccus pancreaticus (1 in 500 cases) 1
Emergency Management Algorithm
Phase 1: Immediate Resuscitation (FIRST PRIORITY)
Critical principle: Resuscitation MUST precede diagnostic attempts. 1, 4
Hemodynamic stabilization:
- Establish large-bore IV access (two lines minimum)
- Aggressive volume resuscitation with crystalloids
- Monitor vital signs continuously (pulse, blood pressure, urine output, central venous pressure if available) 1
Blood transfusion strategy:
- Transfuse at hemoglobin threshold <7 g/dL for patients without cardiovascular disease 5, 6, 7
- Use higher threshold (8 g/dL) for patients with underlying cardiovascular disease or myocardial ischemia 5, 8, 6
- In massive bleeding with hemodynamic instability, transfuse immediately regardless of hemoglobin level 8
Correct coagulopathy:
- Address anticoagulation if present
- Do NOT delay endoscopy for anticoagulation reversal 5
Phase 2: Pre-Endoscopic Pharmacologic Management
Proton pump inhibitor (PPI) therapy:
Prokinetic agent:
For suspected variceal bleeding (cirrhotic patients):
Do NOT use:
Phase 3: Endoscopic Intervention (Diagnostic and Therapeutic)
Timing is critical:
- Standard timing: Within 24 hours of presentation for nonvariceal bleeding after adequate resuscitation 1, 2, 4, 5
- Emergency endoscopy (<12 hours): Required for:
Endoscopy achieves:
- Source identification in 95% of cases 1
- Therapeutic hemostasis
- Prognostic information regarding rebleeding risk 1
- Reduced transfusion requirements and hospital stay 1
Endoscopic therapy indications:
High-risk stigmata requiring intervention:
Low-risk stigmata NOT requiring intervention:
Recommended endoscopic techniques:
- Combination therapy preferred: Epinephrine injection PLUS thermal coagulation (bipolar electrocoagulation, heater probe) OR clips 11, 5, 6, 9
- Epinephrine injection alone is NOT recommended - suboptimal efficacy 11, 5
- Alternative effective methods:
Phase 4: Post-Endoscopic Management
Acid suppression:
Monitoring:
Early feeding:
Discharge criteria:
Phase 5: Management of Refractory or Recurrent Bleeding
If rebleeding occurs:
Repeat endoscopy FIRST to confirm rebleeding and attempt second endoscopic therapy 11, 5, 6
If second endoscopic therapy fails:
Prophylactic TAE may be considered for:
- Hemodynamic instability at presentation
- Posterior duodenal wall ulcer location
- Large ulcer size (>2 cm)
- Uncertain durability of endoscopic hemostasis 9
Critical Pitfalls to Avoid
- Never attempt diagnostic procedures before adequate resuscitation - this increases mortality 1
- Do not use epinephrine injection as monotherapy - always combine with thermal or mechanical therapy 11, 5
- Do not delay endoscopy for anticoagulation reversal in patients on anticoagulants 5
- Do not perform routine second-look endoscopy unless clinically indicated by rebleeding 11
- Avoid midnight-to-7am surgery timing when possible - associated with higher mortality 11
- Remember 75% of UGIB stops spontaneously - but high rebleeding risk necessitates close monitoring 1
Special Considerations
- Mortality remains 2-14% despite advances, emphasizing need for aggressive early management 1, 2
- Consider intubation carefully - avoid if possible, but if necessary, ensure adequate resuscitation first, use preoxygenation, have suction ready, and consider prokinetic agent 8
- Consultant surgeon should be informed early about potential surgical need 11
- Multidisciplinary protocols with trained endoscopists and support staff available urgently improve outcomes 5